February 2, 2018 / 12:01 PM / 4 months ago

Merck posts bigger quarterly loss

Feb 2 (Reuters) - U.S. drugmaker Merck & Co Inc reported a bigger quarterly loss on Friday, partly due to a $2.6 billion charge related to recent changes to the U.S. tax law.

The company said its research and development expenses fell 56 percent to $2.06 billion in the quarter.

Merck’s net loss attributable widened to $872 million, or 32 cents per share, in the fourth quarter, from $594 million, or 22 cents per share, a year earlier. (Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below